NeOnc Technologies Holdings is trading at $2.85, up +5.56%, alongside a broader U.S. technology rebound; available evidence suggests market sentiment but does not confirm it as the cause. - The Nasdaq Composite is up 1.46%. - No company-specific catalyst for October 19 was identified. NeOnc’s latest listed release, on October 16, concerned a compassionate-use patient update and did not report a direct stock-market reaction.